These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33503469)

  • 1. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
    Lagoumintzis G; Chasapis CT; Alexandris N; Kouretas D; Tzartos S; Eliopoulos E; Farsalinos K; Poulas K
    Food Chem Toxicol; 2021 Mar; 149():112009. PubMed ID: 33503469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
    Farsalinos K; Eliopoulos E; Leonidas DD; Papadopoulos GE; Tzartos S; Poulas K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
    Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
    MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors.
    O'Brien BCV; Weber L; Hueffer K; Weltzin MM
    J Biol Chem; 2023 May; 299(5):104707. PubMed ID: 37061001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline.
    Carlson EC; Macsai M; Bertrand S; Bertrand D; Nau J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic cholinergic system and COVID-19:
    Alexandris N; Lagoumintzis G; Chasapis CT; Leonidas DD; Papadopoulos GE; Tzartos SJ; Tsatsakis A; Eliopoulos E; Poulas K; Farsalinos K
    Toxicol Rep; 2021; 8():73-83. PubMed ID: 33425684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.
    Yuan M; Wu NC; Zhu X; Lee CD; So RTY; Lv H; Mok CKP; Wilson IA
    Science; 2020 May; 368(6491):630-633. PubMed ID: 32245784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
    Hussain A; Hasan A; Nejadi Babadaei MM; Bloukh SH; Chowdhury MEH; Sharifi M; Haghighat S; Falahati M
    Biomed Pharmacother; 2020 Oct; 130():110559. PubMed ID: 32768882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
    J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
    Tanmay S; Labrou D; Farsalinos K; Poulas K
    Food Chem Toxicol; 2021 Jun; 152():112184. PubMed ID: 33838172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor.
    Chrestia JF; Oliveira AS; Mulholland AJ; Gallagher T; Bermúdez I; Bouzat C
    Mol Neurobiol; 2022 Oct; 59(10):6076-6090. PubMed ID: 35859025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
    Kalashnyk O; Lykhmus O; Sullivan R; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2024 May; 709():149825. PubMed ID: 38537599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
    Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
    Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptors as SARS-CoV-2 spike co-receptors?
    Dormoy V; Perotin JM; Gosset P; Maskos U; Polette M; Deslée G
    Med Hypotheses; 2022 Jan; 158():110741. PubMed ID: 34924680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence.
    Kalashnyk O; Lykhmus O; Izmailov M; Koval L; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2021 Jul; 561():14-18. PubMed ID: 34000512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model.
    Majumder S; Chaudhuri D; Datta J; Giri K
    J Mol Graph Model; 2021 Jan; 102():107778. PubMed ID: 33099199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study.
    Yu W; Wu X; Ren J; Zhang X; Wang Y; Li C; Xu W; Li J; Li G; Zheng W; Liao H; Yuan X
    Comb Chem High Throughput Screen; 2021; 24(7):1069-1082. PubMed ID: 33106140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental test of the nicotinic hypothesis of COVID-19.
    Godellas NE; Cymes GD; Grosman C
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2204242119. PubMed ID: 36279466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Behloul N; Baha S; Shi R; Meng J
    Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.